Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

4411.56 (Glytoucan)

Id:2620ed7b-89bd-543b-bc97-0daeae1fe07a

Glytoucan:G31787HV

Results found

Linked to

	Label	Description
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G23718VU-GLYCOSEQ00171343 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G22426TD-GLYCOSEQ00173319 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000063 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G52354QX-GLYCOSEQ00192111 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G59742GY-GLYCOSEQ00073094 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has canonical residue n-glycan b-d-galp 66 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G02630BJ-GLYCOSEQ00140858 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G28111YP-GLYCOSEQ00189871 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G23718VU-GLYCOSEQ00171343 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G22426TD-GLYCOSEQ00173319 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000063 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G52354QX-GLYCOSEQ00192111 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000003 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000071 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G59742GY-GLYCOSEQ00073094 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has canonical residue n-glycan b-d-galp 66

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G02630BJ-GLYCOSEQ00140858 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

4411.56 has glycosequence GLYGEN.GLYCOSEQUENCE:G28111YP-GLYCOSEQ00189871 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.